John W. Fabre

8.6k citations

182 papers · 7.0k indexed · 2 hit papers · h-index 44

Transplantation top 0.5%
- Renal Transplantation Outcomes and Treatments 32
Immunology top 0.5%
- T-cell and B-cell Immunology 43
- Immunotherapy and Immune Responses 37
- Immune Cell Function and Interaction 21
Immunology and Allergy top 1%
Radiology, Nuclear Medicine and Imaging top 1%
- Monoclonal and Polyclonal Antibodies Research 40
Hematology top 2%
Molecular Biology
- RNA Interference and Gene Delivery 31
- Glycosylation and Glycoproteins Research 21
Surgery
- Organ Transplantation Techniques and Outcomes 26

Co-authors: Rosemarie Dalchau Peter J. Morris D N Hart A. S. Daar Alan Ting Greta J. Sawyer Derek N.J. Hart Jean Kirkley
Cited by: Transplantation Immunology Immunology and Allergy
Partner nations: United Kingdom Australia France

In The Last Decade

John W. Fabre

179 papers receiving 6.4k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

1981 Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain.
1979 A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody

Peers

Countries citing papers authored by John W. Fabre

Since Specialization

Citations

This map shows the geographic impact of John W. Fabre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Fabre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Fabre more than expected).

Fields of papers citing papers by John W. Fabre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W. Fabre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Fabre. The network helps show where John W. Fabre may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John W. Fabre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John W. Fabre Line = papers co-authored together John W. Fabre links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Nonviral Delivery of the Rat PDX1 Gene to Rat Liver For the In Vivo Transdifferentiation of Liver Cells to Pancreatic Beta-Cells Abdullah Çim,Greta J. Sawyer,Xiahong Zhang,Haibin Su,Louise Collins,Peter M. Jones,Michael Antoniou,Hans J. Lipps,John W. Fabre	2010	4
2	Critical Physiological and Surgical Considerations for Hydrodynamic Gene Delivery to Individual Segments of the Liver in the Rat and Pig Models John W. Fabre,Greta J. Sawyer,Michael Whitehorne,Aidan Grehan,H. Zhang,Mark Davenport,M Rela	2010	1
3	Cardiovascular function following acute volume overload for hydrodynamic gene delivery to the liver Greta J. Sawyer,Xuebin Dong,Michael Whitehorne,Aidan Grehan,Michael D. Seddon,Ajay M. Shah,X Zhang,John W. Fabre	2007	27
4	Trust requirements in identity management Audun Jøsang,John W. Fabre,Brian Hay,James Dalziel,Simon Pope	2005	83
5	The effect of anti-lymphocyte serum on subpopulations of blood and tissue leucocytes: possible supplementary mechanisms for suppression of rejection and the development of opportunistic infections Ina Geissler,Greta J. Sawyer,Xuebin Dong,Hala Kandil,Edward T. Davies,John W. Fabre	2005	4
6	A synthetic peptide vector system for optimal gene delivery to corneal endothelium Louise Collins,John W. Fabre	2004	41
7	The in vivo use of chloroquine to promote non‐viral gene delivery to the liver via the portal vein and bile duct Xiaohong Zhang,Greta J. Sawyer,Xuebin Dong,Ying Qiu,Louise Collins,John W. Fabre	2002	46
8	An Epithelial Cell Line That Can Stimulate Alloproliferation of Resting CD4+ T Cells, But Not After IFN-γ Stimulation Charlotte Lawson,Ann McCormack,David L. Moyes,Sheng Yun,John W. Fabre,Magdi H. Yacoub,Marlene L. Rose	2000	11
9	EFFICIENT GENE DELIVERY TO VASCULAR SMOOTH MUSCLE CELLS USING A NONTOXIC, SYNTHETIC PEPTIDE VECTOR SYSTEM TARGETED TO MEMBRANE INTEGRINS: A FIRST STEP TOWARD THE GENE THERAPY OF CHRONIC REJECTION1 Jian‐Mei Li,Louise Collins,Xiaohong Zhang,Kenth Gustafsson,John W. Fabre	2000	17
10	Medicine as a profession: Hip, Hip, Hippocrates: extracts from The Hippocratic Doctor John W. Fabre	1997	3
11	A NONVIRAL VECTOR SYSTEM FOR EFFICIENT GENE TRANSFER TO CORNEAL ENDOTHELIAL CELLS VIA MEMBRANE INTEGRINS1 Lorna Shewring,Louise Collins,Susan L. Lightman,Stephen L. Hart,Kenth Gustafsson,John W. Fabre	1997	50
12	A THREE-CELL CLUSTER HYPOTHESIS FOR NONCOGNATE T-B COLLABORATION VIA DIRECT T CELL RECOGNITION OF ALLOGENEIC DENDRITIC CELLS1 Catherine M. Kelly,Adam M. Benham,Greta J. Sawyer,Rosemarie Dalchau,John W. Fabre	1996	16
13	Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J. Fangmann,Rosemarie Dalchau,John W. Fabre	1992	182
14	T cell recognition of donor major histocompatibility complex class Ipeptides during allograft rejection J. Fangmann,Rosemarie Dalchau,Greta J. Sawyer,Carol A. Priestley,John W. Fabre	1992	61
15	The PVG-RT1r1 rat carries theHLA-DP-like (RTI.H)α andβ genes of the DA strain Clare A. Carter,John W. Fabre	1991	5
16	Monoclonal antibodies in clinical medicine Andrew J. McMichael,John W. Fabre	1982	65
17	Identification with a monoclonal antibody of a predominantly B lymphocyte-specific determinant of the human leukocyte common antigen. Evidence for structural and possible functional diversity of the human leukocyte common molecule. Rosemarie Dalchau,John W. Fabre	1981	127
18	Studies on the effects of cyclosporin A upon renal allograft rejection in the dog. WILLIAM P. HOMAN,Michael French,Peter Millard,T. Denton,John W. Fabre,Peter J. Morris	1980	25
19	IMMUNOSUPPRESSIVE PROPERTIES OF RABBIT ANTIBODIES AGAINST A MAJOR GLYCOPROTEIN RESTRICTED TO RAT LEUKOCYTE MEMBRANES John W. Fabre,C.A. Sunderland,Abigail Williams	1980	17
20	[Malignant degeneration of fibrous bone dysplasia: general review apropos of 2 cases]. A Pons,J Arlet,Alibelli Mj,M Fabié,John W. Fabre	1974	1

About John W. Fabre

John W. Fabre is a scholar working on Transplantation, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 182 papers that have together received 7.0k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (43 papers), Monoclonal and Polyclonal Antibodies Research (40 papers), Immunotherapy and Immune Responses (37 papers), Renal Transplantation Outcomes and Treatments (32 papers), RNA Interference and Gene Delivery (31 papers), Organ Transplantation Techniques and Outcomes (26 papers), Immune Cell Function and Interaction (21 papers) and Glycosylation and Glycoproteins Research (21 papers). The work is most often cited by research in Transplantation (767 citations), Immunology (3.2k citations) and Immunology and Allergy (496 citations). John W. Fabre has collaborated with scholars based in United Kingdom, Australia and France. Frequent co-authors include Rosemarie Dalchau, Peter J. Morris, D N Hart, A. S. Daar, Alan Ting, Greta J. Sawyer, Derek N.J. Hart, Jean Kirkley, Louise Collins and Sarah C. Spencer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact